MAC
Mason & Associates (California) Portfolio holdings
AUM
$515M
1-Year Est. Return
19.85%
This Fund
S&P 500
1 Year Est. Return
+19.85%
AUM
$515M
AUM Growth
-$16.3M
(-3.1%)
Holding
169
Top Buys
| 1 | +$12.6M | |
| 2 | +$2.48M | |
| 3 | +$2.2M | |
| 4 |
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
+$1.09M |
| 5 |
GraniteShares Gold Shares
BAR
|
+$1.04M |
Top Sells
| 1 | +$5.67M | |
| 2 | +$2.3M | |
| 3 | +$1.16M | |
| 4 |
Dimensional US Equity ETF
DFUS
|
+$1.12M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$978K |
Sector Composition
| 1 | Technology | 9.31% |
| 2 | Financials | 2.87% |
| 3 | Communication Services | 2.52% |
| 4 | Consumer Discretionary | 2.39% |
| 5 | Healthcare | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Baker Hughes
BKR
$68.6B
| $212K | 0.04% |
+3,499
|
|
||
152
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.45B
| $210K | 0.04% |
+3,870
|
|
||
153
iShares Russell Mid-Cap Growth ETF
IWP
$19.5B
| $208K | 0.04% |
1,685
|
|
||
154
dLocal
DLO
$4.06B
| $176K | 0.03% |
+14,215
|
|
||
155
Geron
GERN
$1.01B
| $170K | 0.03% |
120,700
|
|
||
|
FSSL
156
FS Specialty Lending Fund
FSSL
$938M
| $136K | 0.03% |
11,125
-22,033
|
|
||
157
Recursion Pharmaceuticals
RXRX
$1.79B
| $94.6K | 0.02% |
33,300
+135
|
|
||
|
IBO
158
Impact BioMedical
IBO
$70.8M
| $5.85K | ﹤0.01% |
10,000
|
|
||
159
Vertex Pharmaceuticals
VRTX
$108B
| – | – |
-665
|
|
||
160
Oracle
ORCL
$494B
| – | – |
-3,154
|
|
||
161
Morgan Stanley
MS
$300B
| – | – |
-3,248
|
|
||
162
Johnson & Johnson
JNJ
$547B
| – | – |
-1,018
|
|
||
163
Intuitive Surgical
ISRG
$162B
| – | – |
-370
|
|
||
164
Eaton
ETN
$165B
| – | – |
-989
|
|
||
165
Cencora
COR
$59.1B
| – | – |
-640
|
|
||
166
Capital One
COF
$122B
| – | – |
-1,533
|
|
||
167
Blackstone
BX
$155B
| – | – |
-2,548
|
|
||
168
Applovin
APP
$155B
| – | – |
-581
|
|
||
169
Allstate
ALL
$55.9B
| – | – |
-5,568
|
|